查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1660711

心臟生物标记市场报告（按类型（肌钙蛋白、心肌肌酸激酶、肌红蛋白、脑钠肽或 NT-proBNP、缺血修饰白蛋白等）、检测地点、应用和地区划分，2025 年至 2033 年）

Cardiac Biomarkers Market Report by Type (Troponins, Myocardial Muscle Creatine Kinase, Myoglobin, Brain Natriuretic Peptide or NT-proBNP, Ischemia Modified Albumin, and Others), Location of Testing, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球心臟生物标记市场规模达到 115 亿美元。

心臟标誌物，也称为心臟生物标记物，当心臟受到压力或肌肉受损时就会释放到血液中。这些标记物包括不同类型的酵素、荷尔蒙和蛋白质，例如心臟肌钙蛋白、肌酸激酶 (CK)、缺血修饰白蛋白 (IMA) 和肌红蛋白。这些标记物的测量和测试有助于诊断心臟缺血和急性冠状动脉综合征（ACS）等心臟疾病。目前，用于确定这些疾病风险的分类和诊断系统是基于心电图 (ECG) 和临床病史。然而，这些系统是不够的，可能会导致误诊或延迟治疗。由于心臟标记检测具有更高的准确性，并且能够在症状早期识别病情，因此它们在全球范围内越来越受欢迎。这些标记物还可以帮助更准确地监测这些病症的预后并为患者提供最有效的治疗。

全球心臟生物标记市场驱动因素：

在过去几年中，患有 ACS 的患者数量有所增加，这在全球范围内导致了对心臟标记检测的需求。除此之外，患者和医疗保健提供者对早期诊断各种心血管疾病的重要性的认识不断提高，推动了对这些标记物的需求。此外，还有许多私人和公共组织正在投资研发活动，以开发心臟生物标记领域的先进技术。例如，已证明高敏感性心肌肌钙蛋白I的血液检测可以识别出再次心臟病发作风险较高的患者。此外，生物标记检测提供的高精度和快速结果，加上价格合理的心臟即时检测的可用性，也是推动市场成长的其他因素。

本报告解答的关键问题

  • 2024 年全球心臟生物标记市场规模？ 2025 年至 2033 年期间全球心臟生物标记市场的预期成长率为何？
  • 推动全球心臟生物标记市场发展的关键因素有哪些？
  • COVID-19 对全球心臟生物标记市场有何影响？
  • 根据检测地点，全球心臟生物标记市场如何分布？
  • 根据应用，全球心臟生物标记市场如何分布？
  • 全球心臟生物标记市场的关键区域有哪些？
  • 全球心臟生物标记市场的关键公司/参与者有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第五章：全球心臟生物标记市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场区隔：按类型
  • 市场区隔：依测试地点划分
  • 市场区隔：按应用
  • 市场分布：按地区
  • 市场预测

第六章：市场细分：依类型

  • 肌钙蛋白（T 和 I）
    • 市场趋势
    • 市场预测
  • 心肌肌酸激酶（CK-MB）
    • 市场趋势
    • 市场预测
  • 肌红蛋白
    • 市场趋势
    • 市场预测
  • 脑钠肽 (BNPs) 或 NT-proBNP
    • 市场趋势
    • 市场预测
  • 缺血修饰白蛋白 (IMA)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第七章：市场区隔：依测试地点划分

  • 实验室测试
    • 市场趋势
    • 市场预测
  • 即时检验
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 心肌梗塞
    • 市场趋势
    • 市场预测
  • 充血性心臟衰竭
    • 市场趋势
    • 市场预测
  • 急性冠状动脉综合症
    • 市场趋势
    • 市场预测
  • 动脉粥状硬化
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第九章：市场细分：依地区

  • 北美洲
    • 市场趋势
    • 市场预测
  • 亚太地区
    • 市场趋势
    • 市场预测
  • 欧洲
    • 市场趋势
    • 市场预测
  • 中东和非洲
    • 市场趋势
    • 市场预测
  • 拉丁美洲
    • 市场趋势
    • 市场预测

第 10 章：全球心臟生物标记产业：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：全球心臟生物标记产业：价值链分析

第 12 章：全球心臟生物标记产业：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：全球心臟生物标记产业：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Alere Inc.
    • Beckman Coulter
    • Becton, Dickinson And Co.
    • Biomerieux
    • Bio-Rad Laboratories
    • Randox Laboratories
    • Roche Diagnostics Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific
Product Code: SR112025A1178

The global cardiac biomarkers market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.2 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Market Segmentation:

Breakup by Type:

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Breakup by Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America
  • Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

Competitive Landscape:

  • The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global cardiac biomarkers market in 2024?
  • 2.What is the expected growth rate of the global cardiac biomarkers market during 2025-2033?
  • 3.What are the key factors driving the global cardiac biomarkers market?
  • 4.What has been the impact of COVID-19 on the global cardiac biomarkers market?
  • 5.What is the breakup of the global cardiac biomarkers market based on the location of testing?
  • 6.What is the breakup of the global cardiac biomarkers market based on the application?
  • 7.What are the key regions in the global cardiac biomarkers market?
  • 8.Who are the key companies/players in the global cardiac biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Location of Testing
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Type

  • 6.1 Troponins (T and I)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Myocardial Muscle Creatine Kinase (CK-MB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Myoglobin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Ischemia Modified Albumin (IMA)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point of Care Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Myocardial Infarction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Congestive Heart Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Acute Coronary Syndrome
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Atherosclerosis
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Global Cardiac Biomarkers Industry: SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
    • 14.3.2 Alere Inc.
    • 14.3.3 Beckman Coulter
    • 14.3.4 Becton, Dickinson And Co.
    • 14.3.5 Biomerieux
    • 14.3.6 Bio-Rad Laboratories
    • 14.3.7 Randox Laboratories
    • 14.3.8 Roche Diagnostics Corporation
    • 14.3.9 Siemens Healthcare
    • 14.3.10 Thermo Fisher Scientific

List of Figures

  • Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2024
  • Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
  • Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
  • Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million USD), 2025-2033
  • Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cardiac Biomarkers Market Structure
  • Table 7: Global: Cardiac Biomarkers Market: Key Players